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ABSTRACT Microorganisms are a rich source of bioactives; however, chemical iden-
tiﬁcation is a major bottleneck. Strategies that can prioritize the most proliﬁc micro-
bial strains and novel compounds are of great interest. Here, we present an inte-
grated approach to evaluate the biosynthetic richness in bacteria and mine the
associated chemical diversity. Thirteen strains closely related to Pseudoalteromonas
luteoviolacea isolated from all over the Earth were analyzed using an untargeted
metabolomics strategy, and metabolomic proﬁles were correlated with whole-
genome sequences of the strains. We found considerable diversity: only 2% of the
chemical features and 7% of the biosynthetic genes were common to all strains,
while 30% of all features and 24% of the genes were unique to single strains. The
list of chemical features was reduced to 50 discriminating features using a genetic
algorithm and support vector machines. Features were dereplicated by tandem mass
spectrometry (MS/MS) networking to identify molecular families of the same biosyn-
thetic origin, and the associated pathways were probed using comparative genom-
ics. Most of the discriminating features were related to antibacterial compounds, in-
cluding the thiomarinols that were reported from P. luteoviolacea here for the ﬁrst
time. By comparative genomics, we identiﬁed the biosynthetic cluster responsible for
the production of the antibiotic indolmycin, which could not be predicted with stan-
dard methods. In conclusion, we present an efﬁcient, integrative strategy for eluci-
dating the chemical richness of a given set of bacteria and link the chemistry to bio-
synthetic genes.
IMPORTANCE We here combine chemical analysis and genomics to probe for new
bioactive secondary metabolites based on their pattern of distribution within bacte-
rial species. We demonstrate the usefulness of this combined approach in a group
of marine Gram-negative bacteria closely related to Pseudoalteromonas luteoviolacea,
which is a species known to produce a broad spectrum of chemicals. The approach
allowed us to identify new antibiotics and their associated biosynthetic pathways.
Combining chemical analysis and genetics is an efﬁcient “mining” workﬂow for iden-
tifying diverse pharmaceutical candidates in a broad range of microorganisms and
therefore of great use in bioprospecting.
KEYWORDS: Pseudoalteromonas, comparative genomics, natural products,
untargeted metabolomics
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Microorganisms have remarkable biosynthetic capabilities and can produce sec-ondary metabolites with high structural complexity and important biological
activities. Microorganisms in particular have been a rich source of antibiotics (1, 2) and
have served as scaffolds for many other types of drugs. Chemical identiﬁcation of
microbial metabolites is a major bottleneck, and tools that can aid in the prioritization
of the most proliﬁc microbial strains and attractive compounds are of great interest.
The search for novel chemical diversity can be done “upstream,” at the genome
level, or “downstream,” at the metabolite level. Historically, the approach has been to
identify target molecules; however, with the availability of genomes at low costs,
genome mining has become highly attractive (3–6). Genome mining analyses are
greatly aided by several in silico prediction tools (7), such as antiSMASH (8, 9) and
NaPDoS (10) for secondary metabolite pathway identiﬁcation. Several studies have
explored the general genomic capabilities within a group of related bacteria (11–16),
but only a few studies have explored the overall biosynthetic potential and pathway
diversity (17–21). Ziemert et al. (18) compared 75 genomes from three closely related
Salinispora species and predicted 124 distinct biosynthetic pathways, which by far
exceeds the 13 currently known compound classes from these bacteria. The study
underlined the discovery potential in looking at multiple strains within a limited
phylogenetic space, as a third of the predicted pathways were found only in a single
strain.
A large potential is found by combining genome mining with the signiﬁcant
advances in analytical methods for compound identiﬁcation. Building on the versatility,
accuracy, and high sensitivity that liquid chromatography-mass spectrometry (LC-MS)
platforms have achieved, sophisticated algorithms and software suites have been
developed for untargeted metabolomics (22–26). The core of these programs is, ﬁrst,
feature detection (or peak picking), i.e., the identiﬁcation of all signals caused by true
ions (27), and, second, peak alignment, matching identical features across a batch of
samples. Today, many programs consider not only the parent mass and the retention
time (RT) but also the isotopic pattern, ion adducts, charge states, and potential
fragments (27), which greatly improves the conﬁdence in these feature detection
algorithms (28). These high-quality data can be combined with multivariate analysis
tools, which not only aids analysis and interpretation but also forms a perfect basis for
integration with genomic information. Recently, molecular networking has been intro-
duced as a powerful tool in small-molecule genome mining (21, 29, 30). It builds on an
algorithm (31, 32) capable of comparing characteristic fragmentation patterns, thus
highlighting molecular families with the same structural features and potentially the
same biosynthetic origin. This enables the study and comparison of a high number of
samples, at the same time aiding dereplication and tentative structural identiﬁcation or
classiﬁcation (33).
Here, we present an integrated diversity mining approach that links genes, path-
ways, and chemical features at the very ﬁrst stage of the discovery process using a
combination of publicly available prediction tools and machine learning algorithms. We
use genomic data to interrogate the chemical data and vice versa to get an overview
of the biosynthetic capabilities of a group of related organisms and identify unique
strains and compounds suitable for further chemical characterization. We demonstrate
our approach on a unique group of marine bacterial strains all closely related to
Pseudoalteromonas luteoviolacea based on 16S rRNA gene sequence similarity (34, 35).
Previous studies in our lab have shown that it is a highly chemically proliﬁc and diverse
species with strains producing a cocktail of the antibiotics violacein and either penta-
bromopseudilin or indolmycin (36). We use the integrated approach to evaluate the
promise of continued sampling and discovery efforts within this species as demon-
strated by the ﬁnding of an additional group of antibiotics, the thiomarinols.
RESULTS
Thirteen closely related strains previously identiﬁed as P. luteoviolacea by gene se-
quence similarity (36) were analyzed for their genomic potential and ability to produce
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secondary metabolites. The bacteria were cultivated on a complex medium known to
support production of secondary metabolites (37) and extracted sequentially by ethyl
acetate and butanol to obtain broad metabolite coverage. To obtain a global, unbiased
view of the metabolites produced, molecular features were detected by LC-electrospray
ionization (ESI)–high-resolution MS (HRMS) in an untargeted metabolomics experi-
ment. On average, more than ~2,000 molecular features were detected in each strain.
Merging of ESI/ESI data resulted in a total of 7,190 features from the 13 strains
(excluding medium components), with more features detected in positive mode (6,736)
than negative mode (2,151). To facilitate comparison to genomic data, the features
were represented as pan- and core plots commonly used for comparative microbial
genomics (38, 39). Here, core-metabolome features are shared between all strains,
while the pan-metabolome represents the total repertoire of features detected within
the collection (Fig. 1A).
Surprisingly, only 2% of the features were shared between all the strains. In contrast,
30% of all features were unique to single strains. As the number and detection of
features in each strain change with the chosen threshold for feature ﬁltering, the pan-
and core plots were also made based on the 2,000 and 500 most intense features,
respectively (see Fig. S1 in the supplemental material). Here, the same trend was
observed with 6 to 10% core features and 20% unique features. Thus, regardless of
feature ﬁltering settings, the overall pattern of diversity is the same.
To link the chemical diversity to the genomic diversity in these closely related
strains, we analyzed the 13 genomes by different comparative approaches. The average
genome size was approximately 6 Mb with approximately 5,100 putative protein-
encoding genes per strain (see Table S1 in the supplemental material). The correspond-
ing pan- and core-genomic analysis was performed using CMG-biotools (39) (Fig. 1B).
A total of 9,979 protein-encoding genes were predicted in the pan-genome, including
3,322 genes (33%) conserved between all strains; thus, on average, the core genome
constituted ~65% for each strain. Of the accessory genome, 23% of the total genes
(2,329) could be found only in a single strain (singletons/unique genes). Considering
only genes predicted to be involved in secondary metabolism, the diversity was even
higher (Fig. 1C). On average, 8.6% of the total genes were predicted to be allocated to
FIG 1 Pan- and core-metabolome and genome plots of 13 P. luteoviolacea strains. (A) The pan-metabolome curve (blue)
connects the cumulative number of molecular features detected (positive and negative mode merged). The core-
metabolome curve (red) connects the conserved number of features. The bars show the number of newmolecular features
detected in each extract (medium components excluded). (B) Pan-genome (blue) and core-genome (red) curves for all
predicted genes. (C) Pan-genome (blue) and core-genome (red) curves for genes predicted to be involved in secondary
metabolism.
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secondary metabolism (see Table S1), which is extremely high compared to other
sequenced strains belonging to Pseudoalteromonas (40, 41). Similar to the total pan-
genome, 24% (386) of the genes putatively involved in secondary metabolism were
found in only a single strain; however, only 7% (119) were shared between all 13 strains.
Thus, we see approximately a 5-fold-higher genetic diversity in secondary metabolism
compared to the full pan-genome.
The high number of unique genes and molecular features suggests an open
pan-genome/metabolome (38) in which there is a continuous increase in diversity with
continued sampling, which is very attractive for discovery purposes. Both sets of data
suggest that 90% of the diversity/genomic potential for secondary metabolism can be
covered with 10 strains but that each new strain holds promise for new compounds
and biosynthetic pathways.
Pan-genomic diversity and pathway mapping suggest a highly dynamic
accessory genome. To determine the potential evolutionary relationship between
the strains and associated pathways, a pan-genomic map was generated illustrating
shared orthologs between groups of species (Fig. 2).
The method uses a conservative BLAST-based nongreedy pairing of genes, which
results in 2,435 genes found to be present as 1:1 orthologs in all strains, which is slightly
fewer than the 3,388 genes found in the method illustrated in Fig. 1. In general, we
observed two main clades based on shared genes, one consisting of six strains and the
other of seven. Each clade has 190 to 220 genes unique for that clade. The method also
further reﬂects the genetic diversity of each strain, as illustrated in Fig. 1B and C. Based
on the shared orthologs, we generated presence/absence patterns for all genes show-
ing in which other strains that gene has orthologs, a useful starting point for data
correlation.
For genetic analysis of biosynthetic pathways in multiple strains, pathways were
predicted using antiSMASH across the 13 strains and grouped into 37 operational
biosynthetic units (OBUs) (18) (see Table S2 in the supplemental material). OBU
presences were compared to the pan-genomic map (Fig. 2) to trace biosynthetic
pathways. Only 10 pathways were conserved in all strains, including a glycosylated
lantipeptide (RiPP1) and two bacteriocins (RiPP2 and RiPP3). All strains maintained
essential pathways likely responsible for production of siderophores (NRPS1 putative
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FIG 2 Icicle plot of shared genes for groups of species with OBUs overlaid. The numbers in the boxes
show the number of mutual 1:1 orthologs found in the species to the right of that box. The areas of
the individual boxes are proportional to the number of genes.
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catechol-based siderophore) and homoserine lactones (different variations). The viola-
cein pathway vio is also conserved in all strains (consistent with the purple phenotype
of the pseudoalteromonads), in addition to an unassigned type III polyketide synthase
(PKS) and a hybrid nonribosomal peptide synthetase (NRPS)-PKS pathway. Interestingly,
the majority of clusters follow the strain lineage suggested by Fig. 2, suggesting that
many of the pathways have been introduced and retained based on a competitive
advantage of those clusters. More than 50% of the predicted pathways are restricted to
one or two strains, suggesting that many pathways are introduced highly dynamically
(in evolutionary scale). Whether gene gain or gene loss is responsible for the patchy
distribution for most of these OBUs is unclear and was not part of this study. However,
evolutionary studies in other organisms have proven that horizontal gene transfer is an
important part of the evolution of secondary metabolite clusters (18, 42–45). The exact
mechanism of the transfer is not known. No signiﬁcant amount of transposases or other
mobile elements has been found within or in the direct vicinity of the clusters.
Key discriminative metabolites are revealed through feature prioritization
and dereplication of the pan-metabolome by SVM and molecular networking.
To explore the diversity within the pan-metabolome and prioritize chemical features for
more detailed structural analysis, a two-pronged approach was used: multivariate
analysis based on machine learning algorithms and comparative analyses based on the
pattern of conservation generated from the pan-genomic diversity map. A classiﬁer
based on a combination of a genetic algorithm (GA) and support vector machine (SVM)
(46, 47) was used as a feature selection method to ﬁlter the most important features
from the complex data set, starting with the 500 most intense features and reducing it
to the 50 most signiﬁcant features to distinguish all 13 strains (see Table S3 in the
supplemental material). In addition, extracts from all strains were analyzed with LC-
ESI-MS/MS to generate a molecular network (see Fig. S2a for full details) (30). The
candidates identiﬁed by multivariate and comparative analyses were correlated with
the molecular network (29, 33) for dereplication and connection of molecular features
that likely belong to the same structural class and thus biosynthetic pathway. For
example, the vio pathway (48) was found in all 13 strains, and the antibiotic violacein
was a discriminating core feature (see Table S3). In the molecular network, violacein was
found to belong to a molecular family of a minimum of ﬁve related analogues (see
Fig. S2b) likely associated with the vio pathway, including proviolacein and oxyviola-
cein, as well as a novel analogue with two extra hydroxyl groups.
Some strains have lost the ability to produce polyhalogenated com-
pounds. The discriminating features do not necessarily reﬂect the same groupings as
the genomic analyses. Therefore, they can be used as a tag for identifying the
corresponding biosynthetic pathway through correlation with genomic presence/ab-
sence patterns. On the list of descriptive features generated using the SVM (see
Table S3 in the supplemental material), there are six highly halogenated features that
all seem to be restricted to seven strains: CPMOR-2/DSM6061T, S2607/S4060-1,
NCIMB1944/2ta16, and CPMOR-1. To investigate whether halogenation in general is
unique to those strains, a list of features with a high mass defect was made, resulting
in more than 40 halogenated compounds (see Table S4) restricted to the seven strains.
Most of them had no match to known compounds, but many match the structural
scaffolds of polyhalogenated phenols and pyrroles or hybrids thereof (49) and have
expected antibacterial activity (50).
No pathway predicted by antiSMASH had a halogenase incorporated; thus, the
pattern of presence in these seven strains was used to probe for associated clusters.
Indeed, we found an intact group of 11 genes (including two brominases) conserved in
the seven abovementioned strains (see Fig. S3a in the supplemental material). The
recently characterized bmp pathway corresponds to these genes (bmp1 to bmp10) (49)
and is responsible for the production of polybrominated phenols/pyrroles in strain
2ta16 and a putative multidrug transporter (tentatively named bmp11). Surprisingly, all
11 genes were also found in NCIMB1942/NCIMB2035, where no halogenated com-
pounds were detected. Incidentally, in both genomes, the cluster is divided across two
Bacterial Metabolomic and Genomic Mining
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contigs with the break point being in bmp1 in both genomes. Should this be an actual
physical division of the contig, or an inserted unsequenceable repeat sequence, it could
provide an explanation for the lack of halogenated compounds. However, sequencing
of the bmp1 gene in NCIMB2035 revealed a 1-kb insert in the thioesterase (TE) domain
of the gene, likely explaining the lack of compounds (J. Busch, V. Agarwal, A. A. El
Gamal, B. S. Moore, G. W. Rouse, L. Gram, and P. R. Jensen, unpublished data). Also,
bmp1, bmp2, a part of bmp7, and bmp8 to bmp11 were found in S4047-1/S4054, which
suggests that a common ancestor had an intact bmp pathway.
Two of the discriminative features found in the seven strains are two isomeric
dimeric bromophenol-bromopyrrole hybrids with eight bromines in total (see Fig. S4 in
the supplemental material). The monomers corresponding to the likewise novel “tet-
rabromopseudilin” are also found in the extract, suggesting that these “bis-
tetrabromopseudilins” are true compounds rather than artifacts arising from MS in-
source chemistry. Full structural characterization of these low-proton-density
compounds lies beyond the scope of this study but underlines the versatility of the bmp
pathway and associated chemical diversity.
Identiﬁcation of the indolmycin cluster shows resistance genes and poten-
tial quorum sensing (QS) control. Strains S4047-1, S4054, and CPMOR-1 are all
producing the antibiotic indolmycin, as previously reported (36). Indolmycin was
identiﬁed by GA/SVM as a discriminating feature for those three strains. In addition to
indolmycin, the molecular family consisted of the N/C-demethyl- and N/C-didemethyl
indolmycin analogues as well as indolmyceinic acid, a methylated analogue, and two
hydroxylated analogues. Most of these analogues have not been reported from micro-
bial sources, and their tentative structures were veriﬁed by their MS/MS fragmentation
pattern (see Fig. S5 in the supplemental material).
Like violacein, indolmycin is derived from L-tryptophan, but even though the
biosynthetic pathway has been described by feeding studies in Streptomyces (51–53)
and recently characterized genetically (54), the biosynthetic cluster responsible has
never been characterized. The pan-genome was probed for genes with presence/
absence patterns matching the distribution of indolmycin and the related analogues,
which led to the identiﬁcation of 13 clustered genes, suggesting these to be the genetic
basis for indolmycin biosynthesis (Fig. 3). The identiﬁed genes had predicted functions
similar to those expected to be required for the synthesis of indolmycin such as an
aromatic aminotransferase (unk2), aldoketomutase (unk3), S-adenosylmethionine (SAM)
methyltransferase (unk5), and aminotransferase (unk11). We have compared our pro-
posed indolmycin biosynthetic gene cluster to that characterized by Du et al. (54) and
have identiﬁed homologues to the Streptomyces griseus ATCC 12648 genes involved in
biosynthesis of indolmycin (see Fig. S3b in the supplemental material). Indolmycin has
been identiﬁed as a competitive inhibitor of bacterial tryptophan-tRNA ligases (55, 56),
and the putative cluster seems to incorporate a tryptophan-tRNA ligase (unk1), which
FIG 3 Putative biosynthetic cluster (A) and proposed biosynthetic scheme (B) (51) for indolmycin. CoA, coenzyme A.
Maansson et al.
Volume 1 Issue 3 e00028-15 msystems.asm.org 6
in Streptomyces griseus has been found to confer resistance to indolmycin (56). Inter-
estingly, the cluster in Pseudoalteromonas is ﬂanked by luxI and luxR homologues,
something which is not observed in S. griseus, suggesting that the indolmycin pathway
potentially could be under regulation by quorum sensing.
Thiomarinols add to the antibiotic cocktail. The strains 2ta16 and NCIMB1944
were identiﬁed as hot spots for biosynthetic diversity based on Fig. 2. This was
supported by 313 chemical features (RT and m/z pairs) unique to these two strains.
Based on the GA/SVM, they can be distinguished from the rest of the strains based on
a feature with m/z 640 and an RT of 9.73 min (C30H44N2O9S2), tentatively identiﬁed as
thiomarinol A. Thiomarinols are hybrid NRPS-PKS compounds based on pseudomonic
acid and pyrrothine. One of the gene clusters (hybrid NRPSPKS5) restricted to the pair
2ta16-NCIMB1944 was found to have high similarity to that of pseudomonic acid (mup)
(57) and the recently characterized thiomarinol (tml) cluster (58), corroborating the
ﬁnding of the compound class. Thiomarinols have previously reported antibacterial
activities from Pseudoalteromonas sp. strain SANK 73390 (59, 60).
In the molecular network, it was possible to identify a whole series of thiomarinol
and pseudomonic acid analogues (Fig. 4A and D), all restricted to NCIMB1944 and
2ta16. In addition to thiomarinols A to D, pseudomonic acid C amide and its hydroxyl
analogue could be assigned based on the characteristic MS/MS fragmentation pattern
(Fig. 4B and C). Besides the known analogues, two novel analogues with formulas
C25H43NO8 and C34H51NO11 could be identiﬁed. Both shared the marinolic acid moiety
based on the C6H6O2 (m/z 110.0368) fragment and the loss of C11H2OO4 (m/z 216.1362);
however, they contained only a single nitrogen and no sulfur, indicating a completely
new type of thiomarinol based on neither a holothine nor an ornithine “head” like the
known analogues (Fig. 4C).
DISCUSSION
Advances in genomics and metabolomics have signiﬁcantly increased our ability to
generate high-quality data on microbial secondary metabolism at a very high speed.
This, in turn, has enabled a completely new approach to drug discovery combining the
two “-omics” approaches.
Using a combination of comparative metabolomics and genomics, we ﬁnd a high
potential and remarkable diversity in terms of secondary metabolite production for
strains closely related to P. luteoviolacea. Overall, 8.6% of the genes are allocated to
secondary metabolism, and on average, 10 NRPS/PKS-related OBUs are predicted. This
is very high considering the relatively small size of the genomes (~6 Mb) and is
comparable to that of recognized proliﬁc species such as Salinispora arenicola (10.9% of
5.8 Mb) (13, 18, 61) and Streptomyces coelicolor (8% of 8.7 Mb) (62). Our data suggest
an open pan-genome which is characteristic for species that are adapted to several
types of environments (63), i.e., being both planktonic and associated with marine
macroalgal surfaces. The pan-genome is a dynamic descriptor that will change with the
number of strains and the speciﬁc subset. Nonetheless, our ﬁndings correlate with
comparative genomic studies of other bacterial species (11, 12, 14, 63).
We found ~5-fold-higher genetic diversity in secondary metabolism compared to
the full pan-genome, which supports the idea that production of secondary metabo-
lites is a functionally adaptive trait (64, 65). More than half of the 41 predicted pathways
are restricted to one or two strains, while only 10 pathways were shared between all.
This is similar to ﬁndings in Salinispora (18), where 78% of the pan-genome is associated
with one or two strains. Violacein (66, 67), indolmycin (68, 69), and pentabromopseu-
dilin (49) are all examples of cosmopolitan antibiotics found in unrelated species; thus,
we hypothesize that P. luteoviolacea acquired and retained biosynthetic genes linked
to, e.g., antibiotic production as part of adapting to a speciﬁc niche that it commonly
occupies.
Diversity is further supported at the chemical level. Using unbiased global metab-
olite proﬁling, we identify 7,000 putative chemical features among the 13 analyzed
strains. As the number of chemical features depends on the ﬁltering threshold, this
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should not be seen as an absolute number of compounds that can be isolated and fully
characterized. However, it provides an unbiased estimate of diversity, which in this case
does not seem to change with the chosen threshold. Surprisingly, only 2% of the
features were shared between all the strains. To the best of our knowledge, there is only
one other similar study on chemical diversity in limited taxonomical spaces approach-
ing the species level. Krug et al. (19, 70) analyzed 98 isolates of Myxococcus xanthus in
a semitargeted approach and found 11 out of 51 identiﬁed compounds to be shared
between all strains and a similar fraction present in only one or two strains. We found
that almost half of all features and one-third of the 500 most intense features could be
assigned to one or two strains (thus taking into account the almost clonal strains),
which underlines a great potential for unique chemistry within a group of closely
related strains. The detected chemical diversity is higher than what was found on the
genetic level, which is to be expected, as the method at this initial screening level does
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FIG 4 (A) Molecular network of the thiomarinol/pseudomonic acid molecular family. Dashed nodes indicate
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(C) Structures and suggested fragmentation of thiomarinols A and B and pseudomonic acid C amide. (D) Table
of detected analogues in strains NCIMB1944 and 2ta16.
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not allow for detecting differential regulation of complete pathways or individual
analogues.
The remarkable chemical diversity can be found even within the same sample.
Strains S4047, S4054, and S4060 were all collected from seaweed from the same
geographical location (37). Strains S4047 and S4054 share 99% of their gene families
(clonal) and 70% of their chemical features, but strain S4060 shares only 24% of gene
families and 30% of features with the other two. It is also reﬂected in the biosynthetic
pathways, where nine pathways were found in S4060 but not in S4047 and S4054. This
is a fascinating ecological conundrum as the accessory metabolites and genes usually
are considered to answer the immediate, more localized needs for the strains. None-
theless, this is not the ﬁrst report of such an occurrence. Vos and Velicer (71) found 21
genotypes of M. xanthus using multilocus sequence typing among 78 strains collected
from soil on a centimeter scale. Likewise, signiﬁcant differences have been found in the
chemical proﬁles of cooccurring strains of M. xanthus (19) and Salinibacter ruber (72). In
contrast, NCIMB1944 and 2ta16, which originate from the Mediterranean Sea (France)
and the Florida Keys (United States), respectively, share 99% of their gene families and
70% of their features. That demonstrates that genomic content can be relatively
conserved across biogeographical locations, suggesting a high selective pressure to
conserve those genes despite an overall low degree of chemoconsistency.
In this study, SVM was applied in conjunction with GA to compile a list of 50
chemical features of interest for further structural characterization. Based on SVM, the
reduced set of features are the ones that maximize the difference between samples,
which in this study is exploited to select features unique to each strain or a subset of
strains. GA works as a wrapper to select features to be evaluated in the SVM classiﬁer
(73). The intrinsic nature of the GA makes it highly suitable for discovery purposes as
it favors diversity in how the subset of features is selected (47). To the best of our
knowledge, there are only a few examples of the use of SVM in untargeted secondary
metabolite proﬁling (74, 75). The list of discriminating features highlights key metab-
olites, both in the core and in the accessory metabolome. Of the 50 discriminating
features, only 15 could be tentatively assigned to known compound classes. In this
speciﬁc case, the list even reﬂects the four antibiotic classes identiﬁed in this species,
underlining the utility of GA/SVM to prioritize not only strains but also compounds
before the rate-limiting step of structural identiﬁcation. The combination with molec-
ular networking further strengthens this approach as it makes it possible to identify
structural analogues that likely have similar biological activities.
This is the one of the ﬁrst examples (20, 21, 29) of direct coupling of genomic and
metabolomic data at a global level and at this early stage of the discovery process. By
solely using the patterns of presence/absence across the pan-genome in conjunction
with synteny, we could identify gene clusters without relying on the functions. This
allowed for the identiﬁcation of the pentabromopseudilin and indolmycin gene clus-
ters. Combined with presence/absence of molecular features, this is an extremely
powerful tool for translation back and forth between the genome and metabolome.
Thus, it is possible to identify speciﬁc compounds using genomic queries or to
speciﬁcally identify a gene cluster based on chemistry. Of course, in order to fully
conﬁrm the link between a compound and its genes, knockout mutants need to be
analyzed or entire pathways recombinantly expressed, but here, single candidates for
clusters could be directly and rapidly identiﬁed.
The combination of metabolomics and genomic data identiﬁes obvious hot spots
for chemical diversity among the 13 strains, which permits intelligent strain selection
for more detailed chemical analyses. By randomly picking a single strain, in the worst
case, only 38% of the 500 most intense chemical features (and thus most relevant from
a drug discovery perspective) are covered (NCIMB2035). However, when maximizing
strain orthogonality by selecting the two strains (NCIMB1944 and CPMOR-1) with the
highest number of unique genes, pathways, and chemical features, 82% of the diversity
can be covered. This is extremely important as the isolation and full structural charac-
terization of these compounds still represent the greatest bottleneck in the discovery
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process. This study shows that investigation of multiple closely related strains is a
valuable strategy for detection of new compounds and is imperative for uncovering the
full biosynthetic potential of a species.
MATERIALS AND METHODS
Strains, cultivation, and sample preparation for chemical analyses. The 13 strains included in the
study were collected or donated to us as previously described (36, 37). We did attempt to build a larger
collection; however, P. luteoviolacea autolyzes very easily, and in most laboratories, it has not been
possible to store and revive strains. The strains were cultured in biological duplicates in marine broth
(MB; Difco catalog no. 2216) at 25°C (200 rpm) for 48 h before extraction. See details in Text S1 in the
supplemental material.
LC-MS and LC-MS/MS data acquisition. LC-MS and MS/MS analyses were performed on an Agilent
6550 iFunnel quadrupole-time of ﬂight (Q-TOF) LC-MS (Agilent Technologies, Santa Clara, CA) coupled to
an Agilent 1290 Inﬁnity ultrahigh-performance liquid chromatography (UHPLC) system. Separation was
performed using a Poroshell 120 phenyl-hexyl column (Agilent; 250 mm by 2.1 mm; 2.7 m) with a
water-acetonitrile (ACN) gradient. MS data were recorded in both positive and negative electrospray (ESI)
mode in the m/z 100- to 1,700-Da mass range. Data for molecular networking were collected using a
data-dependent LC-MS/MS as reported previously (76) with optimized collision energies and scan speed.
See Text S1 in the supplemental material for the full experimental setup, procedures, and method
parameters.
Feature extraction and multivariate analysis. Extraction of chemical features was performed using
MassHunter (Agilent Technologies; v.B06.00) and the Molecular Features Extraction (MFE) algorithm and
recursive analysis workﬂow. Feature lists were imported to Genespring-Mass Proﬁler Professional (MPP)
(Agilent Technologies; v.12.6) and ﬁltered with features resulting from the medium removed. The feature
lists from ESI and ESI data were merged in a table as generic data and reimported into MPP. The data
were then normalized and aligned, resulting in a single list of chemical features for each sample. The list
of discriminating features was generated in MPP using a genetic algorithm with a population size of 25,
10 generations, and a mutation rate of 1. The GA was evaluated using the SVM with a linear kernel type
with an imposed cost of 100 and a ratio of 1. The feature list was validated via the leave-one-out method.
Further details and settings can be found in the supplemental material. All 50 discriminating features (see
Table S3 in the supplemental material) were manually veriﬁed to be present in the original data sets.
Molecular formulas were predicted from the accurate mass of the molecular ion or related adducts (77)
as well as the isotope pattern and matched against AntiMarin (v.08.13) and Metlin (78) databases to
tentatively assign known compounds.
Molecular networking. For molecular networking, raw LC-MS/MS data were converted to .mgf using
MSConvert from the ProteoWizard project (79) and analyzed with the algorithm described in the work
of Watrous et al. (30). A new, public interface at http://gnps.ucsd.edu has been made public at the time
of writing, and the data have been deposited (MSV000078988) in the corresponding database, http://
massive.ucsd.edu. Likewise, the annotated MS/MS spectra for all the identiﬁed compounds have been
uploaded and added to the GNPS spectral library. The network corresponding to a cosine value of more
than 0.7 was visualized using Cytoscape 2.8.3 (80).
DNA extraction, genome sequencing, and assembly. Cultures were grown in MB for 1 to 2 days,
and genomic DNA was isolated using either the JGI phenol-chloroform extraction protocol or the Qiagen
100/G kit. Library preparation and 150-base-paired end sequencing were done at the Beijing Genomics
Institute (BGI) on the Illumina HiSeq 2000 system. At least 100-fold coverage was achieved for all genome
sequences generated in this study. Raw sequence data for strain 2ta16 were downloaded from http://
www.jcvi.org and assembled as described here. Genomes were assembled using CLC Genomics Work-
bench (v.2.1 for NCIMB2035, 2.04 for remaining whole-genome sequences) with default settings.
Genome analysis. Contigs were analyzed and plots were created using the CMG-biotools package
as described in the work of Vesth et al. (39). Brieﬂy, genes were predicted using Prodigal 2.00. Gene
families were constructed by genome-wide and pairwise BLAST comparisons. Genes were considered
part of the same gene family with a sequence identity of 50% over at least 50% of the length of the
longest gene. A pan-genomic dendrogram based on occurrences of gene families was used to sort input
order by clustering prior to generating the pan- and core-genome plots (14).
Putative biosynthetic pathways were predicted from sequences (FASTA) with antiSMASH 2.0 (8, 9),
with KS and C domains of PKS and NRPS predicted with NaPDoS (10) using default settings. Pathways
were assessed as being similar OBUs when MultiGeneBlast (81) analyses revealed that 80% of the genes
in the pathway were present with homologues that show at least 60% amino acid identity. For
assessment and assembly of pathways split between different contigs, the sequences of homologues on
the same contig were used as the scaffold. MultiGeneBlast (81) was used for recursive OBU analysis across
all 13 strains, thus providing pseudoscaffolds for larger pathways, which in turn give higher conﬁdence
in the assignments. Partial pathways with the same pattern of conservation were combined in order to
avoid overestimation of diversity. Predicted genes involved in the putative indolmycin biosynthetic
pathway are labeled unk for “unknown.”
Mapping of genes shared by groups of strains. All predicted sets of protein sequences for the 13
strains were compared using the blastp function from the BLAST suite (82). These 169 whole-genome
BLAST tables were analyzed to identify bidirectional best hits in all pairwise comparisons. Using custom
Python scripts, this output was analyzed to identify, for all proteins, the strains in which orthologs were
found. This allowed identiﬁcation of unique genes, genes shared by clades and subclades of species, and
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genes shared by all 13 strains of Pseudoalteromonas. The script also generates a binary 13-digit barcode
of the presence/absence of gene orthologs across the 13 strains for all proteins in the pan-genome.
Nucleotide sequence accession numbers. The whole-genome shotgun projects have been depos-
ited at GenBank under the accession numbers AUXS00000000, AUXT00000000, AUXU00000000,
AUXV00000000, AUXX00000000, AUXY00000000, AUXZ00000000, AUYA00000000, AUYB00000000, and
AUYC00000000. The versions described in this paper are versions AUXS01000000, AUXT01000000,
AUXU01000000, AUXV01000000, AUXX01000000, AUXY01000000, AUXZ01000000, AUYA01000000,
AUYB01000000, and AUYC01000000.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://dx.doi.org/10.1128/
mSystems.00028-15.
Text S1, DOCX ﬁle, 0.1 MB.
Figure S1, DOCX ﬁle, 0.2 MB.
Figure S2, DOCX ﬁle, 0.4 MB.
Figure S3, DOCX ﬁle, 0.1 MB.
Figure S4, DOCX ﬁle, 0.1 MB.
Figure S5, DOCX ﬁle, 0.4 MB.
Table S1, DOCX ﬁle, 0.1 MB.
Table S2, DOCX ﬁle, 0.1 MB.
Table S3, DOCX ﬁle, 0.1 MB.
Table S4, DOCX ﬁle, 0.1 MB.
ACKNOWLEDGMENTS
We acknowledge Farooq Azam and Krystal Rypien of the Scripps Institution of Ocean-
ography, UCSD, for supplying strain 2ta16; Antonio Sanchez-Amat of the University of
Murcia for supplying strains CPMOR-1 and CPMOR-2; and Tillman Harder of the
University of New South Wales for supplying strains H33 and H33S. We thank Mingxun
Wang for assistance with uploads to GNPS/MassIVE and Inge Kjærbølling for help with
Fig. S2 in the supplemental material.
This study was supported by the Danish Research Council for Technology and
Production Science with Sapere Aude (grant no. 116262). Instrumentation and software
used in this study were supported by Agilent Technologies Thought Leader Donation.
The work of J.L.N. and M.R.A. was partially supported by the Villum Foundation (grant
VKR023437). P.C.D. and D.D.N. were supported by the National Institutes of Health (NIH)
(grant GM097509), and L.M.S. was supported by the National Institutes of Health
IRACDA K12 GM068524 grant award.
M.M., N.G.V., and L.G. designed the research; M.M., N.G.V., and J.M. carried out the
experiments; M.M., A.K., N.G.V., D.D.N., L.M.S., N.Z., and M.R.A. analyzed the data; J.L.N.,
M.R.A., and P.C.D. provided methods and algorithms; M.M., A.K., M.R.A., and L.G. wrote
the paper.
FUNDING INFORMATION
This work, including the efforts of Maria Månsson, Nikolaj G Vynne, Jette Melchiorsen,
and Lone Gram, was funded by Danish Research Council for Technology and Produc-
tion (116262). This work, including the efforts of Jane L Nybo and Mikael Rørdam
Andersen, was funded by Villum Fonden (Villum Foundation) (VKR023437). This work,
including the efforts of Don D Nguyen and Pieter C. Dorrestein, was funded by HHS |
National Institutes of Health (NIH) (GM097509). This work, including the efforts of Laura
M Sanchez, was funded by HHS | National Institutes of Health (NIH) (GM068524).
This study was supported by the Danish Research Council for Technology and Produc-
tion Science with Sapere Aude (grant #116262). Instrumentation and software used in
this study was supported by Agilent Technologies Thought Leader Donation. The
work of J.L.N. and M.R.A. was partially supported by the Villum Foundation (grant
VKR023437). P.C.D. and D.D.N. was supported by National Institute of Health
(NIH)(grant GM097509) and L.M.S. by National Institutes of Health IRACDA K12
GM068524 grant award.
Bacterial Metabolomic and Genomic Mining
Volume 1 Issue 3 e00028-15 msystems.asm.org 11
REFERENCES
1. Peláez F. 2006. The historical delivery of antibiotics from microbial
natural products—can history repeat? Biochem Pharmacol 71:981–990.
http://dx.doi.org/10.1016/j.bcp.2005.10.010.
2. Clardy J, Fischbach MA, Walsh CT. 2006. New antibiotics from bacterial
natural products. Nat Biotechnol 24:1541–1550. http://dx.doi.org/
10.1038/nbt1266.
3. Müller R, Wink J. 2014. Future potential for anti-infectives from bacte-
ria—how to exploit biodiversity and genomic potential. Int J Med
Microbiol 304:3–13. http://dx.doi.org/10.1016/j.ijmm.2013.09.004.
4. Aigle B, Lautru S, Spiteller D, Dickschat JS, Challis GL, Leblond P,
Pernodet J-L. 2014. Genome mining of Streptomyces ambofaciens. J Ind
Microbiol Biotechnol 41:251–263. http://dx.doi.org/10.1007/s10295-013
-1379-y.
5. Durkin AS, Eisen JA, Eisen J, Ronning CM, Barbazuk WB, Blanchard
M, Field C, Halling C, Hinkle G, Iartchuk O, Kim HS, Mackenzie C,
Madupu R, Miller N, Shvartsbeyn A, Sullivan SA. 2006. Evolution of
sensory complexity recorded in a myxobacterial genome. Proc Natl Acad
Sc i U S A 103:15200 –15205 . ht tp : / /dx .do i .o rg/10 .1073/
pnas.0607335103.
6. Hanamoto A, Takahashi C, Shinose M, Takahashi Y, Horikawa H,
Nakazawa H, Osonoe T, Kikuchi H, Shiba T, Sakaki Y, Hattori M.
2001. Genome sequence of an industrial microorganism Streptomyces
avermitilis: deducing the ability of producing secondary metabolites.
Proc Natl Acad Sci U S A 98:12215–12220. http://dx.doi.org/10.1073/
pnas.211433198.
7. Weber T. 2014. In silico tools for the analysis of antibiotic biosynthetic
pathways. Int J Med Microbiol 304:230–235. http://dx.doi.org/10.1016/
j.ijmm.2014.02.001.
8. Medema MH, Blin K, Cimermancic P, de Jager V, Zakrzewski P,
Fischbach MA, Weber T, Takano E, Breitling R. 2011. antiSMASH: rapid
identiﬁcation, annotation and analysis of secondary metabolite biosyn-
thesis gene clusters in bacterial and fungal genome sequences. Nucleic
Acids Res 39:W339–W346. http://dx.doi.org/10.1093/nar/gkr466.
9. Blin K, Medema MH, Kazempour D, Fischbach MA, Breitling R,
Takano E, Weber T. 2013. antiSMASH 2.0—a versatile platform for
genome mining of secondary metabolite producers. Nucleic Acids Res
41:W204–W212. http://dx.doi.org/10.1093/nar/gkt449.
10. Ziemert N, Podell S, Penn K, Badger JH, Allen E, Jensen PR. 2012. The
natural product domain seeker NaPDoS: a phylogeny based bioinfor-
matic tool to classify secondary metabolite gene diversity. PLoS One
7:e34064. http://dx.doi.org/10.1371/journal.pone.0034064.
11. Mann RA, Smits TH, Bühlmann A, Blom J, Goesmann A, Frey JE,
Plummer KM, Beer SV, Luck J, Duffy B, Rodoni B. 2013. Comparative
genomics of 12 strains of Erwinia amylovora identiﬁes a pan-genome
with a large conserved core. PLoS One 8:e55644. http://dx.doi.org/
10.1371/journal.pone.0055644.
12. Park J, Zhang Y, Buboltz AM, Zhang X, Schuster SC, Ahuja U, Liu M,
Miller JF, Sebaihia M, Bentley SD, Parkhill J, Harvill ET. 2012. Com-
parative genomics of the classical Bordetella subspecies: the evolution
and exchange of virulence-associated diversity amongst closely related
pathogens. BMC Genomics 13:545. http://dx.doi.org/10.1186/1471-2164
-13-545.
13. Penn K, Jensen PR. 2012. Comparative genomics reveals evidence of
marine adaptation in Salinispora species. BMC Genomics 13:86. http://
dx.doi.org/10.1186/1471-2164-13-86.
14. Lukjancenko O, Wassenaar TM, Ussery DW. 2010. Comparison of 61
sequenced Escherichia coli genomes. Microb Ecol 60:708–720. http://
dx.doi.org/10.1007/s00248-010-9717-3.
15. Tagomori K, Iida T, Honda T. 2002. Comparison of genome structures
of vibrios, bacteria possessing two chromosomes. J Bacteriol 184:
431–4358. http://dx.doi.org/10.1128/JB.184.16.4351-4358.2002.
16. Aylward FO, McDonald BR, Adams SM, Valenzuela A, Schmidt RA,
Goodwin LA, Woyke T, Currie CR, Suen G, Poulsen M. 2013. Compar-
ison of 26 sphingomonad genomes reveals diverse environmental ad-
aptations and biodegradative capabilities. Appl Environ Microbiol 79:
3724–3733. http://dx.doi.org/10.1128/AEM.00518-13.
17. Penn K, Jenkins C, Nett M, Udwary DW, Gontang EA, McGlinchey RP,
Foster B, Lapidus A, Podell S, Allen EE, Moore BS, Jensen PR. 2009.
Genomic islands link secondary metabolism to functional adaptation in
marine Actinobacteria. ISME J 3:1193–1203. http://dx.doi.org/10.1038/
ismej.2009.58.
18. Ziemert N, Lechner A, Wietz M, Millán-Aguiñaga N, Chavarria KL,
Jensen PR. 2014. Diversity and evolution of secondary metabolism in
the marine actinomycete genus Salinispora. Proc Natl Acad Sci U S A
2014:1–10. http://dx.doi.org/10.1073/pnas.1324161111.
19. Krug D, Zurek G, Revermann O, Vos M, Velicer GJ, Müller R. 2008.
Discovering the hidden secondary metabolome of Myxococcus xanthus:
a study of intraspeciﬁc diversity. Appl Environ Microbiol 74:3058–3068.
http://dx.doi.org/10.1128/AEM.02863-07.
20. Doroghazi JR, Albright JC, Goering AW, Ju K-S, Haines RR, Tchalu-
kov KA, Labeda DP, Kelleher NL, Metcalf WW. 2014. A roadmap for
natural product discovery based on large-scale genomics and metabo-
lomics. Nat Chem Biol 10:963–968. http://dx.doi.org/10.1038/
nchembio.1659.
21. Duncan KR, Crüsemann M, Lechner A, Sarkar A, Li J, Ziemert N,
Wang M, Bandeira N, Moore BS, Dorrestein PC, Jensen PR. 2015.
Molecular networking and pattern-based genome mining improves dis-
covery of biosynthetic gene clusters and their products from Salinispora
species. Chem Biol 22:460 – 471. http://dx.doi.org/10.1016/
j.chembiol.2015.03.010.
22. Lommen A. 2009. MetAlign: interface-driven, versatile metabolomics
tool for hyphenated full-scan mass spectrometry data preprocessing.
Anal Chem 81:3079–3086. http://dx.doi.org/10.1021/ac900036d.
23. Katajamaa M, Miettinen J, Oresic M. 2006. MZmine: toolbox for pro-
cessing and visualization of mass spectrometry based molecular proﬁle
data. Bioinformatics 22:634 – 636. http://dx.doi.org/10.1093/
bioinformatics/btk039.
24. Pluskal T, Castillo S, Villar-Briones A, Oresic M. 2010. MZmine 2:
modular framework for processing, visualizing, and analyzing mass
spectrometry-based molecular proﬁle data. BMC Bioinformatics 11:395.
http://dx.doi.org/10.1186/1471-2105-11-395.
25. Kuhl C, Tautenhahn R, Böttcher C, Larson TR, Neumann S. 2012.
CAMERA: an integrated strategy for compound spectra extraction and
annotation of liquid chromatography/mass spectrometry data sets. Anal
Chem 84:283–289. http://dx.doi.org/10.1021/ac202450g.
26. Tautenhahn R, Patti GJ, Rinehart D, Siuzdak G. 2012. XCMS online: a
web-based platform to process untargeted metabolomic data. Anal
Chem 84:5035–5039. http://dx.doi.org/10.1021/ac300698c.
27. Katajamaa M, Oresic M. 2007. Data processing for mass spectrometry-
based metabolomics. J Chromatogr A 1158:318–328. http://dx.doi.org/
10.1016/j.chroma.2007.04.021.
28. Lange E, Tautenhahn R, Neumann S, Gröpl C. 2008. Critical assess-
ment of alignment procedures for LC-MS proteomics and metabolomics
measurements. BMC Bioinformatics 9:375. http://dx.doi.org/10.1186/
1471-2105-9-375.
29. Nguyen DD, Wu C-H, Moree WJ, Lamsa A, Medema MH, Zhao X,
Gavilan RG, Aparicio M, Atencio L, Jackson C, Ballesteros J, Sanchez
J, Watrous JD, Phelan VV, van de Wiel C, Kersten RD, Mehnaz S, De
Mot R, Shank EA, Charusanti P. 2013. MS/MS networking guided
analysis of molecule and gene cluster families. Proc Natl Acad Sci U S A
110:E2611–E2620. http://dx.doi.org/10.1073/pnas.1303471110.
30. Watrous J, Roach P, Alexandrov T, Heath BS, Yang JY, Kersten RD,
van der Voort M, Pogliano K, Gross H, Raaijmakers JM, Moore BS,
Laskin J, Bandeira N, Dorrestein PC. 2012. Mass spectral molecular
networking of living microbial colonies. Proc Natl Acad Sci U S A
109:E1743–E1752. http://dx.doi.org/10.1073/pnas.1203689109.
31. Ng J, Bandeira N, Liu W-T, Ghassemian M, Simmons TL, Gerwick WH,
Linington R, Dorrestein PC, Pevzner PA. 2009. Dereplication and de
novo sequencing of nonribosomal peptides. Nat Methods 6:596–599.
http://dx.doi.org/10.1038/nmeth.1350.
32. Liu W-T, Ng J, Meluzzi D, Bandeira N, Gutierrez M, Simmons TL,
Schultz AW, Linington RG, Moore BS, Gerwick WH, Pevzner PA,
Dorrestein PC. 2009. Interpretation of tandem mass spectra obtained
from cyclic nonribosomal peptides. Anal Chem 81:4200–4209. http://
dx.doi.org/10.1021/ac900114t.
33. Yang JY, Sanchez LM, Rath CM, Liu X, Boudreau PD, Bruns N,
Glukhov E, Wodtke A, De Felicio R, Fenner A, Wong WR, Linington
RG, Zhang L, Debonsi HM, Gerwick WH, Dorrestein PC. 2013. Molec-
ular networking as a dereplication strategy. J Nat Prod 76:1686–1699.
http://dx.doi.org/10.1021/np400413s.
34. Bowman JP. 2007. Bioactive compound synthetic capacity and ecolog-
Maansson et al.
Volume 1 Issue 3 e00028-15 msystems.asm.org 12
ical signiﬁcance of marine bacterial genus Pseudoalteromonas. Mar
Drugs 5:220–241. http://dx.doi.org/10.3390/md504220.
35. Holmström C, Kjelleberg S. 1999. Marine Pseudoalteromonas species
are associated with higher organisms and produce biologically active
extracellular agents. FEMS Microbiol Ecol 30:285–293.
36. Vynne NG, Mansson M, Gram L. 2012. Gene sequence based clustering
assists in dereplication of Pseudoalteromonas luteoviolacea strains with
identical inhibitory activity and antibiotic production. Mar Drugs 10:
1729–1740. http://dx.doi.org/10.3390/md10081729.
37. Gram L, Melchiorsen J, Bruhn JB. 2010. Antibacterial activity of marine
culturable bacteria collected from a global sampling of ocean surface
waters and surface swabs of marine organisms. Mar Biotechnol (NY)
12:439–451. http://dx.doi.org/10.1007/s10126-009-9233-y.
38. Medini D, Donati C, Tettelin H, Masignani V, Rappuoli R. 2005. The
microbial pan-genome. Curr Opin Genet Dev 15:589–594. http://
dx.doi.org/10.1016/j.gde.2005.09.006.
39. Vesth T, Lagesen K, Acar Ö, Ussery D. 2013. CMG-biotools, a free
workbench for basic comparative microbial genomics. PLoS One
8:e60120. http://dx.doi.org/10.1371/journal.pone.0060120.
40. Thomas T, Evans FF, Schleheck D, Mai-Prochnow A, Burke C, Pene-
syan A, Dalisay DS, Stelzer-Braid S, Saunders N, Johnson J, Ferriera
S, Kjelleberg S, Egan S. 2008. Analysis of the Pseudoalteromonas
tunicata genome reveals properties of a surface-associated life style in
the marine environment. PLoS One 3:e3252. http://dx.doi.org/10.1371/
journal.pone.0003252.
41. Médigue C, Krin E, Pascal G, Barbe V, Bernsel A, Bertin PN, Cheung
F, Cruveiller S, D’Amico S, Duilio A, Fang G, Feller G, Ho C,
Mangenot S, Marino G, Nilsson J, Parrilli E, Rocha EP, Rouy Z,
Sekowska A, Tutino ML, Vallenet D, von Heijne G, Danchin A. 2005.
Coping with cold: the genome of the versatile marine Antarctica bacte-
rium Pseudoalteromonas haloplanktis TAC125. Genome Res 15:
1325–1335. http://dx.doi.org/10.1101/gr.4126905.
42. Mofﬁtt MC, Neilan BA. 2003. Evolutionary afﬁliations within the super-
family of ketosynthases reﬂect complex pathway associations. J Mol Evol
56:446–457. http://dx.doi.org/10.1007/s00239-002-2415-0.
43. Jenke-Kodama H, Börner T, Dittmann E. 2006. Natural biocombinato-
rics in the polyketide synthase genes of the actinobacterium Streptomy-
ces avermitilis. PLoS Comput Biol 2:e132. http://dx.doi.org/10.1371/
journal.pcbi.0020132.
44. Zucko J, Long PF, Hranueli D, Cullum J. 2012. Horizontal gene transfer
and gene conversion drive evolution of modular polyketide synthases. J
Ind Microbiol Biotechnol 39:1541–1547. http://dx.doi.org/10.1007/
s10295-012-1149-2.
45. Jenke-Kodama H, Dittmann E. 2009. Evolution of metabolic diversity:
insights from microbial polyketide synthases. Phytochemistry 70:
1858–1866. http://dx.doi.org/10.1016/j.phytochem.2009.05.021.
46. Lin X, Yang F, Zhou L, Yin P, Kong H, Xing W, Lu X, Jia L, Wang Q,
Xu G. 2012. A support vector machine-recursive feature elimination
feature selection method based on artiﬁcial contrast variables and mu-
tual information. J Chromatogr B Analyt Technol Biomed Life Sci 910:
149–155. http://dx.doi.org/10.1016/j.jchromb.2012.05.020.
47. Lin X, Wang Q, Yin P, Tang L, Tan Y, Li H, Yan K, Xu G. 2011. A method
for handling metabonomics data from liquid chromatography/mass
spectrometry: combinational use of support vector machine recursive
feature elimination, genetic algorithm and random forest for feature
selection. Metabolomics 7:549–558. http://dx.doi.org/10.1007/s11306
-011-0274-7.
48. Zhang X, Enomoto K. 2011. Characterization of a gene cluster and its
putative promoter region for violacein biosynthesis in Pseudoalteromo-
nas sp. 520P1. Appl Microbiol Biotechnol 90:1963–1971. http://
dx.doi.org/10.1007/s00253-011-3203-9.
49. Agarwal V, El Gamal AA, Yamanaka K, Poth D, Kersten RD, Schorn
M, Allen EE, Moore BS. 2014. Biosynthesis of polybrominated aromatic
organic compounds by marine bacteria. Nat Chem Biol 10:640–647.
http://dx.doi.org/10.1038/nchembio.1564.
50. Laatsch H, Renneberg B, Hanefeld U, Kellner M, Pudleiner H, Ham-
precht G, Kraemer HP, Anke H. 1995. Structure-activity-relationships of
phenylpyrroles and benzoylpyrroles. Chem Pharm Bull 43:537–546.
http://dx.doi.org/10.1248/cpb.43.537.
51. Hornemann U, Hurley LH, Speedie MK, Floss HG. 1971. The biosyn-
thesis of indolmycin. J Am Chem Soc 93:3028–3035.
52. Woodard RW, Mascaro L, Horhammer R, Eisenstein S, Floss HG. 1980.
Stereochemistry of indolmycin biosynthesis. Steric course of C- and
N-methylation reactions. J Am Chem Soc 102:6314–6318.
53. Speedie MK, Hornemann U, Floss HG. 1975. Isolation and character-
ization of tryptophan and indolepyruvate C-methyltransferase. Enzymes
involved in indolmycin biosynthesis in Streptomyces griseus. J Biol
Chem 250:7819–7825.
54. Du Y-L, Alkhalaf LM, Ryan KS. 2015. In vitro reconstitution of indol-
mycin biosynthesis reveals the molecular basis of oxazolinone assembly.
Proc Natl Acad Sci U S A 112:2717–2722. http://dx.doi.org/10.1073/
pnas.1419964112.
55. Vecchione JJ, Sello JK. 2009. A novel tryptophanyl-tRNA synthetase
gene confers high-level resistance to indolmycin. Antimicrob Agents
Chemother 53:3972–3980. http://dx.doi.org/10.1128/AAC.00723-09.
56. Kitabatake M, Ali K, Demain A, Sakamoto K, Yokoyama S, Söll D.
2002. Indolmycin resistance of Streptomyces coelicolor A3(2) by induced
expression of one of its two tryptophanyl-tRNA synthetases. J Biol Chem
277:23882–23887. http://dx.doi.org/10.1074/jbc.M202639200.
57. El-Sayed AK, Hothersall J, Cooper SM, Stephens E, Simpson TJ,
Thomas CM. 2003. Characterization of the mupirocin biosynthesis gene
cluster from Pseudomonas ﬂuorescens NCIMB 10586. Chem Biol 10:
419–430. http://dx.doi.org/10.1016/S1074-5521(03)00091-7.
58. Fukuda D, Haines AS, Song Z, Murphy AC, Hothersall J, Stephens ER,
Gurney R, Cox RJ, Crosby J, Willis CL, Simpson TJ, Thomas CM. 2011.
A natural plasmid uniquely encodes two biosynthetic pathways creating
a potent anti-MRSA antibiotic. PLoS One 6:e18031. http://dx.doi.org/
10.1371/journal.pone.0018031.
59. Shiozawa H, Kagasaki T, Torikata A, Tanaka N, Fujimoto K, Hata T,
Furukawa Y, Takahashi S. 1995. Thiomarinols B and C, new antimicro-
bial antibiotics produced by a marine bacterium. J Antibiot 48:907–909.
http://dx.doi.org/10.7164/antibiotics.48.907.
60. Shiozawa H, Shimada A, Takahashi S. 1997. Thiomarinols D, E, F and
G, new hybrid antimicrobial antibiotics produced by a marine bacterium;
isolation, structure and antimicrobial activity. J Antibiot 50:449–452.
http://dx.doi.org/10.7164/antibiotics.50.449.
61. Udwary DW, Zeigler L, Asolkar RN, Singan V, Lapidus A, Fenical W,
Jensen PR, Moore BS. 2007. Genome sequencing reveals complex
secondary metabolome in the marine actinomycete Salinispora tropica.
Proc Natl Acad Sci U S A 104:10376–10381. http://dx.doi.org/10.1073/
pnas.0700962104.
62. Thomson NR, James KD, Harris DE, Quail MA, Bentley SD, Harper D,
Bateman A, Brown S, Collins M, Cronin A, Fraser A, Goble A, Hidalgo
J, Hornsby T, Howarth S, Larke L, Murphy L, Oliver K, Rabbinowitsch
E, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R,
Squares S, Taylor K, Warren T, Woodward J, Barrell BG, Parkhill J.
2002. Complete genome sequence of the model actinomycete Strepto-
myces coelicolor A3(2). Nature 417:141–147. http://dx.doi.org/10.1038/
417141a.
63. Tettelin H, Masignani V, Cieslewicz MJ, Donati C, Medini D, Ward NL,
Angiuoli SV, Crabtree J, Jones AL, Durkin AS, Deboy RT, Davidsen
TM, Mora M, Scarselli M, Margarit y Ros I, Peterson JD, Hauser CR,
Sundaram JP, Nelson WC, Madupu R, Brinkac LM, Dodson RJ, Roso-
vitz MJ, Sullivan SA, Daugherty SC, Haft DH, Selengut J, Gwinn ML,
Zhou L, Zafar N, Khouri H, Radune D, Dimitrov G, Watkins K,
O’Connor KJB, Smith S, Utterback TR, White O, Rubens CE, Grandi G,
Madoff LC, Kasper DL, Telford JL, Wessels MR, Rappuoli R, Fraser
CM. 2005. Genome analysis of multiple pathogenic isolates of Strepto-
coccus agalactiae: implications for the microbial “pan-genome.” Proc
Natl Acad Sci U S A 102:13950–13955.
64. Osbourn A. 2010. Secondary metabolic gene clusters: evolutionary
toolkits for chemical innovation. Trends Genet 26:449–457. http://
dx.doi.org/10.1016/j.tig.2010.07.001.
65. Firn RD. 2003. Bioprospecting—why is it so unrewarding? Biodivers
Conserv 12:207–216. http://dx.doi.org/10.1023/A:1021928209813.
66. Tobie WC. 1935. The pigment of Bacillus violaceus: I. The production,
extraction, and puriﬁcation of violacein. J Bacteriol 29:223–227.
67. Yada S, Wang Y, Zou Y, Nagasaki K, Hosokawa K, Osaka I, Arakawa
R, Enomoto K. 2008. Isolation and characterization of two groups of
novel marine bacteria producing violacein. Mar Biotechnol (NY) 10:
128–132. http://dx.doi.org/10.1007/s10126-007-9046-9.
68. Von Wittenau MS, Els H. 1963. Chemistry of indolmycin. J Am Chem
Soc 85:3425–3431. http://dx.doi.org/10.1021/ja00904a028.
69. Månsson M, Phipps RK, Gram L, Munro MH, Larsen TO, Nielsen KF.
2010. Explorative solid-phase extraction (E-SPE) for accelerated microbial
natural product discovery, dereplication, and puriﬁcation. J Nat Prod
73:1126–1132. http://dx.doi.org/10.1021/np100151y.
70. Krug D, Zurek G, Schneider B, Garcia R, Müller R. 2008. Efﬁcient
Bacterial Metabolomic and Genomic Mining
Volume 1 Issue 3 e00028-15 msystems.asm.org 13
mining of myxobacterial metabolite proﬁles enabled by liquid
chromatography-electrospray ionisation-time-of-ﬂight mass spectrome-
try and compound-based principal component analysis. Anal Chim Acta
624:97–106. http://dx.doi.org/10.1016/j.aca.2008.06.036.
71. Vos M, Velicer GJ. 2006. Genetic population structure of the soil
bacterium Myxococcus xanthus at the centimeter scale. Appl Environ
Microbiol 72:3615–3625. http://dx.doi.org/10.1128/AEM.72.5.3615
-3625.2006.
72. Antón J, Lucio M, Peña A, Cifuentes A, Brito-Echeverría J, Moritz F,
Tziotis D, López C, Urdiain M, Schmitt-Kopplin P, Rosselló-Móra R.
2013. High metabolomic microdiversity within co-occurring isolates of
the extremely halophilic bacterium Salinibacter ruber. PLoS One
8:e64701. http://dx.doi.org/10.1371/journal.pone.0064701.
73. Li S, Kang L, Zhao X-M. 2014. A survey on evolutionary algorithm based
hybrid intelligence in bioinformatics. Biomed Res Int 2014:362738.
http://dx.doi.org/10.1155/2014/362738.
74. Boccard J, Kalousis A, Hilario M, Lantéri P, Hanaﬁ M, Mazerolles G,
Wolfender J, Carrupt P, Rudaz S. 2010. Standard machine learning
algorithms applied to UPLC-TOF/MS metabolic ﬁngerprinting for the
discovery of wound biomarkers in Arabidopsis thaliana. Chemometr
I n t e l l L ab Sy s t 104 :20 –27 . h t tp : / / d x . do i . o rg / 10 . 1016 /
j.chemolab.2010.03.003.
75. Mahadevan S, Shah SL, Marrie TJ, Slupsky CM. 2008. Analysis of
metabolomic data using support vector machines. Anal Chem 80:
7562–7570. http://dx.doi.org/10.1021/ac800954c.
76. Kildgaard S, Mansson M, Dosen I, Klitgaard A, Frisvad JC, Larsen TO,
Nielsen KF. 2014. Accurate dereplication of bioactive secondary metab-
olites from marine-derived fungi by UHPLC-DAD-QTOFMS and a MS/
HRMS Library. Mar Drugs 12:3681–3705. http://dx.doi.org/10.3390/
md12063681.
77. Nielsen KF, Månsson M, Rank C, Frisvad JC, Larsen TO. 2011. Derep-
lication of microbial natural products by LC-DAD-TOFMS. J Nat Prod
74:2338–2348. http://dx.doi.org/10.1021/np200254t.
78. Smith CA, O’Maille G, Want EJ, Qin C, Trauger SA, Brandon TR,
Custodio DE, Abagyan R, Siuzdak G. 2005. METLIN: a metabolite mass
spectral database. Ther Drug Monit 27:747–751. http://dx.doi.org/
10.1097/01.ftd.0000179845.53213.39.
79. Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, Neu-
mann S, Gatto L, Fischer B, Pratt B, Egertson J, Hoff K, Kessner D,
Tasman N, Shulman N, Frewen B, Baker TA, Brusniak M, Paulse C,
Creasy D, Flashner L, Kani K, Moulding C, Seymour SL, Nuwaysir LM,
Lefebvre B, Kuhlmann F, Roark J, Rainer P, Detlev S, Hemenway T,
Huhmer A, Langridge J, Connolly B, Chadick T, Holly K, Eckels J,
Deutsch EW, Moritz RL, Katz JE, Agus DB, MacCoss M, Tabb DL,
Mallick P. 2012. A cross-platform toolkit for mass spectrometry and
proteomics. Nat Biotechnol 30:918–920. http://dx.doi.org/10.1038/
nbt.2377.
80. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T. 2011. Cytoscape
2.8: new features for data integration and network visualization. Bioin-
formatics 27:431–432. http://dx.doi.org/10.1093/bioinformatics/btq675.
81. Medema MH, Takano E, Breitling R. 2013. Detecting sequence homol-
ogy at the gene cluster level with MultiGeneBlast. Mol Biol Evol 30:
1218–1223. http://dx.doi.org/10.1093/molbev/mst025.
82. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer
K, Madden TL. 2009. BLAST: architecture and applications. BMC Bioin-
formatics 10:421. http://dx.doi.org/10.1186/1471-2105-10-421.
83. Sullivan MJ, Petty NK, Beatson SA. 2011. Easyﬁg: a genome compar-
ison visualizer. Bioinformatics 27:1009–1010. http://dx.doi.org/10.1093/
bioinformatics/btr039.
Maansson et al.
Volume 1 Issue 3 e00028-15 msystems.asm.org 14
